Mass Tort News6 min readDupixent CTCL Lawsuits: The Next Emerging MDLPlaintiffs are moving to centralize Dupixent cutaneous T-cell lymphoma cases as an MDL after the FDA flagged a safety signal.mass tortDupixentemerging litigation+2Jun 8, 2026Read
